查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2032586

抗纖溶藥物市場報告：按適應症、劑型、最終用戶和地區分類（2026-2034 年）

Antifibrinolytic Drugs Market Report by Indication, Form, End User, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 135 Pages | 商品交期: 2-3個工作天內

價格

2025年全球抗纖溶藥物市場規模達183億美元。展望未來，IMARC Group預測，到2034年，該市場規模將達到251億美元，2026年至2034年的複合年成長率為3.47%。

抗纖溶藥物是一類促進血栓形成的藥物，旨在防止動脈和靜脈中的纖溶或阻塞。這些藥物抑制胞漿素原原活化，阻止纖維蛋白溶解並維持血栓穩定性。它們用於治療出血和肝血管瘤，以及緩解月經過多。此外，它們還用於控制侵入性手術期間和術後的出血。常用的抗纖溶藥物包括氨甲環酸、抑肽酶、氨基己酸和絲胺酸蛋白酶抑制劑。這些藥物廣泛用於治療口腔咽部、鼻腔、胃腸道以及子宮和陰道黏膜的出血。因此，它們在醫院、診所、創傷中心和門診手術中心中廣泛使用。

抗纖溶藥物市場趨勢：

交通事故、創傷和各種出血性疾病發生率的上升是市場成長的主要促進因素之一。此外，抗纖溶藥物在治療女性月經量過多以及預防心血管和神經外科手術出血方面的應用日益廣泛，也促進了市場成長。抗纖溶藥物對於防止溶栓和減少出血至關重要。同時，公眾健康意識的提高以及對遺傳性血管性水腫和血友病治療方案的了解也促進了市場成長。各種技術的進步以及抗纖溶療法在整形外科患者中減少輸血的廣泛應用是其他成長要素。製藥公司也在開發具有更高療效和生物利用度的創新口服和靜脈注射藥物。其他因素，例如老年人口的成長和醫療基礎設施的顯著改善，預計也將推動市場成長。

市場區隔:

本報告分析了全球抗纖溶藥物市場各細分領域的關鍵趨勢，並提出了2026年至2034年的全球、區域和國家特定預測。市場按適應症、劑型和最終用戶進行細分。

按適應症細分：

  • 婦科
  • 遺傳性血管性水腫
  • 纖維蛋白溶解反應試驗
  • 外科手術
  • 其他

按類型細分：

  • 口服
  • 注射藥物

按最終用戶分類：

  • 醫院和診所
  • 門診手術中心
  • 創傷中心
  • 其他

按地區分類：

  • 北美洲
  • 我們
  • 加拿大
  • 亞太地區
  • 中國
  • 日本
  • 印度
  • 韓國
  • 澳洲
  • 印尼
  • 其他
  • 歐洲
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙
  • 俄羅斯
  • 其他
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 其他
  • 中東和非洲

競爭格局：

報告中還檢驗了該行業的競爭格局，並介紹了主要參與者的概況，例如 ACIC Pharmaceuticals Inc.、Akorn Inc.、Aurobindo Pharma Limited、Ferring Pharmaceuticals、Novartis AG、Pfizer Inc.、Takeda Pharmaceutical Company Limited、Viatris Inc. 和 Vitruvias Therapeutics Inc.。

本報告解答的主要問題

1. 抗纖溶藥物市場規模有多大？

2. 2026 年至 2034 年全球抗纖溶藥物市場的預期成長率為何？

3. 推動全球抗纖溶藥物市場發展的主要因素是什麼？

4. COVID-19 對全球抗纖溶藥物市場產生了哪些影響？

5. 全球抗纖溶藥物市場依適應症分類的結構是怎樣的？

6. 全球抗纖溶藥物市場的主要區域有哪些？

7. 全球抗纖溶藥物市場的主要公司和參與者有哪些？

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球抗纖溶藥物市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依適應症分類

  • 婦科
  • 遺傳性血管性水腫
  • 纖維蛋白溶解反應試驗
  • 外科手術
  • 其他

第7章 市場區隔：依形式

  • 口服
  • 注射藥物

第8章 市場區隔：依最終用戶分類

  • 醫院和診所
  • 門診手術中心
  • 創傷中心
  • 其他

第9章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第10章 SWOT 分析

第11章：價值鏈分析

第12章：波特五力分析

第13章：價格分析

第14章 競爭格局

  • 市場結構
  • 大公司
  • 主要公司簡介
    • ACIC Pharmaceuticals Inc.
    • Akorn Inc.
    • Aurobindo Pharma Limited
    • Ferring Pharmaceuticals
    • Novartis AG
    • Pfizer Inc.
    • Takeda Pharmaceutical Company Limited
    • Viatris Inc.
    • Vitruvias Therapeutics Inc.
Product Code: SR112026A5672

The global antifibrinolytic drugs market size reached USD 18.3 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 25.1 Billion by 2034, exhibiting a growth rate (CAGR) of 3.47% during 2026-2034.

Antifibrinolytic drugs refer to the pharmaceutical medicines used for promoting the formation of blood clots to prevent fibrinolysis or blockage in arteries and veins. These drugs inhibit the activation of plasminogen, thereby preventing the lysis of fibrin and maintaining clot stability. They are used for the treatment of hemorrhages, vascular tumors and providing relief from heavy menstrual bleeding. They are also used for controlling bleeding during or after invasive surgeries. Some commonly available antifibrinolytic drugs include tranexamic acid, aprotinin, aminocaproic acid and serine protease inhibitors. They are widely used for the management of mucosal bleeding in the oropharynx, nose, gastrointestinal (GI) tract and uterine-vaginal linings. As a result, they are extensively used across hospitals, clinics and trauma and ambulatory surgical centers.

Antifibrinolytic Drugs Market Trends:

The rising incidence of road accidents, traumas and various bleeding disorders is one of the key factors driving the growth of the market. Moreover, the widespread adoption of antifibrinolytic drugs to prevent blood loss in women suffering from menorrhagia and during cardiovascular and neurosurgeries is providing a thrust to the market growth. Antifibrinolytic drugs are essential for preventing clot lysis and minimizing blood loss. In line with this, increasing health consciousness and awareness among the masses regarding the available treatment alternatives for hereditary angioedema and hemophilia are also contributing to the growth of the market. Various technological advancements and the increasing utilization of antifibrinolytic therapy to reduce transfusion in orthopedic patients are acting as other growth-inducing factors. Pharmaceutical manufacturers are also developing innovative oral and intravenous drug variants with enhanced efficacy and bio-absorbability. Other factors, including the rising geriatric population and significant improvements in the healthcare infrastructure, are anticipated to drive the market toward growth.

Market Segmentation:

This report provides an analysis of the key trends in each sub-segment of the global antifibrinolytic drugs market report, along with forecasts at the global, regional and country level from 2026-2034. The report categorizes the market based on indication, form and end user.

Breakup by Indication:

  • Gynecology
  • Hereditary Angioedema
  • Fibrinolytic Response Testing
  • Surgeries
  • Others

Breakup by Form:

  • Oral
  • Injectable

Breakup by End User:

  • Hospitals and Clinics
  • Ambulatory Surgical Centers
  • Trauma Centers
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being ACIC Pharmaceuticals Inc., Akorn Inc., Aurobindo Pharma Limited, Ferring Pharmaceuticals, Novartis AG, Pfizer Inc., Takeda Pharmaceutical Company Limited, Viatris Inc. and Vitruvias Therapeutics Inc.

Key Questions Answered in This Report

1. How big is the antifibrinolytic drugs market?

2. What is the expected growth rate of the global antifibrinolytic drugs market during 2026-2034?

3. What are the key factors driving the global antifibrinolytic drugs market?

4. What has been the impact of COVID-19 on the global antifibrinolytic drugs market?

5. What is the breakup of the global antifibrinolytic drugs market based on the indication?

6. What are the key regions in the global antifibrinolytic drugs market?

7. Who are the key players/companies in the global antifibrinolytic drugs market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Antifibrinolytic Drugs Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Indication

  • 6.1 Gynecology
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Hereditary Angioedema
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Fibrinolytic Response Testing
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Surgeries
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Form

  • 7.1 Oral
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Injectable
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals and Clinics
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Ambulatory Surgical Centers
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Trauma Centers
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 ACIC Pharmaceuticals Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Akorn Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Aurobindo Pharma Limited
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
    • 14.3.4 Ferring Pharmaceuticals
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Novartis AG
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Pfizer Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Takeda Pharmaceutical Company Limited
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Viatris Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
    • 14.3.9 Vitruvias Therapeutics Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio

List of Figures

  • Figure 1: Global: Antifibrinolytic Drugs Market: Major Drivers and Challenges
  • Figure 2: Global: Antifibrinolytic Drugs Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Antifibrinolytic Drugs Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 4: Global: Antifibrinolytic Drugs Market: Breakup by Indication (in %), 2025
  • Figure 5: Global: Antifibrinolytic Drugs Market: Breakup by Form (in %), 2025
  • Figure 6: Global: Antifibrinolytic Drugs Market: Breakup by End User (in %), 2025
  • Figure 7: Global: Antifibrinolytic Drugs Market: Breakup by Region (in %), 2025
  • Figure 8: Global: Antifibrinolytic Drugs (Gynecology) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 9: Global: Antifibrinolytic Drugs (Gynecology) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 10: Global: Antifibrinolytic Drugs (Hereditary Angioedema) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 11: Global: Antifibrinolytic Drugs (Hereditary Angioedema) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 12: Global: Antifibrinolytic Drugs (Fibrinolytic Response Testing) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 13: Global: Antifibrinolytic Drugs (Fibrinolytic Response Testing) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 14: Global: Antifibrinolytic Drugs (Surgeries) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 15: Global: Antifibrinolytic Drugs (Surgeries) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 16: Global: Antifibrinolytic Drugs (Other Indications) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 17: Global: Antifibrinolytic Drugs (Other Indications) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 18: Global: Antifibrinolytic Drugs (Oral) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 19: Global: Antifibrinolytic Drugs (Oral) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 20: Global: Antifibrinolytic Drugs (Injectable) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 21: Global: Antifibrinolytic Drugs (Injectable) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 22: Global: Antifibrinolytic Drugs (Hospitals and Clinics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 23: Global: Antifibrinolytic Drugs (Hospitals and Clinics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 24: Global: Antifibrinolytic Drugs (Ambulatory Surgical Centers) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 25: Global: Antifibrinolytic Drugs (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 26: Global: Antifibrinolytic Drugs (Trauma Centers) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 27: Global: Antifibrinolytic Drugs (Trauma Centers) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 28: Global: Antifibrinolytic Drugs (Other End Users) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 29: Global: Antifibrinolytic Drugs (Other End Users) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 30: North America: Antifibrinolytic Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 31: North America: Antifibrinolytic Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 32: United States: Antifibrinolytic Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 33: United States: Antifibrinolytic Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 34: Canada: Antifibrinolytic Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 35: Canada: Antifibrinolytic Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 36: Asia-Pacific: Antifibrinolytic Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 37: Asia-Pacific: Antifibrinolytic Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 38: China: Antifibrinolytic Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 39: China: Antifibrinolytic Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 40: Japan: Antifibrinolytic Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 41: Japan: Antifibrinolytic Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 42: India: Antifibrinolytic Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 43: India: Antifibrinolytic Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 44: South Korea: Antifibrinolytic Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 45: South Korea: Antifibrinolytic Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 46: Australia: Antifibrinolytic Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 47: Australia: Antifibrinolytic Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 48: Indonesia: Antifibrinolytic Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 49: Indonesia: Antifibrinolytic Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 50: Others: Antifibrinolytic Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 51: Others: Antifibrinolytic Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 52: Europe: Antifibrinolytic Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 53: Europe: Antifibrinolytic Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 54: Germany: Antifibrinolytic Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 55: Germany: Antifibrinolytic Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 56: France: Antifibrinolytic Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 57: France: Antifibrinolytic Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 58: United Kingdom: Antifibrinolytic Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 59: United Kingdom: Antifibrinolytic Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 60: Italy: Antifibrinolytic Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 61: Italy: Antifibrinolytic Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 62: Spain: Antifibrinolytic Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 63: Spain: Antifibrinolytic Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 64: Russia: Antifibrinolytic Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 65: Russia: Antifibrinolytic Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 66: Others: Antifibrinolytic Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 67: Others: Antifibrinolytic Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 68: Latin America: Antifibrinolytic Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 69: Latin America: Antifibrinolytic Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 70: Brazil: Antifibrinolytic Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 71: Brazil: Antifibrinolytic Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 72: Mexico: Antifibrinolytic Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 73: Mexico: Antifibrinolytic Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 74: Others: Antifibrinolytic Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 75: Others: Antifibrinolytic Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 76: Middle East and Africa: Antifibrinolytic Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 77: Middle East and Africa: Antifibrinolytic Drugs Market: Breakup by Country (in %), 2025
  • Figure 78: Middle East and Africa: Antifibrinolytic Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 79: Global: Antifibrinolytic Drugs Industry: SWOT Analysis
  • Figure 80: Global: Antifibrinolytic Drugs Industry: Value Chain Analysis
  • Figure 81: Global: Antifibrinolytic Drugs Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Antifibrinolytic Drugs Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Antifibrinolytic Drugs Market Forecast: Breakup by Indication (in Million USD), 2026-2034
  • Table 3: Global: Antifibrinolytic Drugs Market Forecast: Breakup by Form (in Million USD), 2026-2034
  • Table 4: Global: Antifibrinolytic Drugs Market Forecast: Breakup by End User (in Million USD), 2026-2034
  • Table 5: Global: Antifibrinolytic Drugs Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 6: Global: Antifibrinolytic Drugs Market: Competitive Structure
  • Table 7: Global: Antifibrinolytic Drugs Market: Key Players